Trademarkia Logo

Canada

C$
REBLOZEL
REGISTERED

on 12 Oct 2017

Last Applicant/ Owned by

CELGENE CORPORATION

Route 206 & Province Line RoadPrinceton, NJ 08543

US

Serial Number

1785382 filed on 3rd Jun 2016

Registration Number

TMA982705 registered on 12th Oct 2017

Registration expiry Date

12th Oct 2032

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

REBLOZEL

Trademark usage description

pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoimmune disease, blood disease, cancer, art Read More

Classification Information


Class [005]
Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoimmune disease, blood disease, cancer, arthritis in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations, namely, cytokine inhibitory drugs for use in the treatment of autoimmune diseases; pharmaceutical preparations, for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; hematological tumors and solid tumors.


Classification kind code

10

Mark Details


Serial Number

1785382

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 50
on 29th Sept 2017
Allowed
Submitted for opposition 42
on 14th Jun 2017
Advertised
Submitted for opposition 26
on 25th May 2017
Approved
Submitted for opposition 27
on 4th Apr 2017
Approval Notice Sent
Submitted for opposition 15
on 10th Jan 2017
Correspondence Created
Submitted for opposition 22
on 2th Dec 2016
Search Recorded
Submitted for opposition 20
on 2th Dec 2016
Examiner's First Report
Submitted for opposition 30
on 3rd Jun 2016
Filed
Submitted for opposition 1
on 3rd Jun 2016
Created
Submitted for opposition 31
on 3rd Jun 2016
Formalized